Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BIOCUREX INC (BOCX) -- Ignore unavailable to you. Want to Upgrade?

To: afrayem onigwecher who wrote (15)	3/11/2003 11:35:04 AM
From: scion	Read Replies (1) \| Respond to of 21

Huge market potential - no product to sell to it - is that correct? A vaccine based on BOCX's proprietary RECAFTM technology that would protect against most types of cancer has a $2B market potential in U.S. alone. It sounds like all those companies that said "there is a huge Chinese market - all we need is 2% to get rich".

To: afrayem onigwecher who wrote (15)	3/11/2003 11:38:47 AM
From: scion	Respond to of 21

RECAF(TM ) Word Mark RECAF Goods and Services (CANCELLED) IC 030. US 046. G & S: SUGAR-SIZED PACKETS CONTAINING CAFFEINE WHICH MAY BE ADDED TO BEVERAGES SUCH AS COFFEE. FIRST USE: 19861201. FIRST USE IN COMMERCE: 19861201 Mark Drawing Code (3) DESIGN PLUS WORDS, LETTERS, AND/OR NUMBERS Design Search Code 241501 241510 260109 Serial Number 73644197 Filing Date February 12, 1987 Published for Opposition December 22, 1987 Registration Number 1494426 Registration Date June 28, 1988 Owner (REGISTRANT) DEVICK, STEVEN D. INDIVIDUAL UNITED STATES 1106 MIDWEST CLUB PARKWAY OAK BROOK ILLINOIS 60521 Attorney of Record ROBERT S. BAKER Type of Mark TRADEMARK Register PRINCIPAL Live/Dead Indicator DEAD Cancellation Date April 13, 1995 tess2.uspto.gov